This bid is closed — responses were due July 30, 2026.
It is no longer accepting submissions. We keep closed bids on BidsNexus for reference: agencies often re-issue the same need, and past bids show what they buy and when.
This bid is for the late-stage clinical development, regulatory approval, and subsequent procurement of 2-PAM autoinjectors, a drug/device combination product, for treating organophosphate poisoning in both adult and pediatric populations under Project Bioshield.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Late-stage clinical development of 2-PAM autoinjectors (adult and pediatric populations)
1
project
$100,000,000.00
$100,000,000.00
Professional Services
Regulatory approval (FDA) for 2-PAM autoinjectors (adult and pediatric populations)
1
project
$50,000,000.00
$50,000,000.00
Professional Services
Procurement of 2-PAM autoinjectors (drug/device combination product)
1
lot
$150,000,000.00
$150,000,000.00
Medical
Estimated Bid Value
$300,000,000.00
Want the full details?
Sign up free to see the agency name and the original bid posting link. Pro adds the 2 documents, contracting-officer contacts and AI response outlines.